Indonesia Ranked as World's Top E-Cigarette Consumer

Market by 2FIRSTS.ai
Jan.10.2024
Indonesia Ranked as World's Top E-Cigarette Consumer
Indonesia leads the world in e-cigarette consumption, with 25% of respondents admitting to using them, according to a survey.

According to Validnews, a news organization in Indonesia, Agus Dwi Susanto, the chairman of the Indonesian Association of Respiratory Disease Experts (PDPI), has stated that Indonesia is now the largest consumer of e-cigarettes in the world.

 

The statement refers to the results of the Statista Consumer Insights survey conducted from January to March 2023. As many as 25% of Indonesian respondents answered that they have used e-cigarettes at least once. This proportion is higher than that of Switzerland (16%), the United States (15%), and the United Kingdom (13%).

 

Angus DeVeyng, during an online media briefing held on January 9th, stated, "This is targeted towards adolescents."

 

Subsequently, he cited a study conducted by Friendship Hospital in 2021, revealing a societal shift from e-cigarettes to traditional cigarettes. A staggering 76.7% of respondents believe that e-cigarettes have lower nicotine content.

 

They also believe that e-cigarettes can be used as a nicotine replacement therapy. However, in reality, e-cigarettes do not meet the requirements for smoking cessation treatment. This is because they fail to meet eight fundamental principles.

 

Firstly, individuals who participate in NRT (Nicotine Replacement Therapy) must cease smoking. However, in Indonesia, the use of e-cigarettes actually encourages a significant number of dual users, who are both e-cigarette consumers and traditional smokers.

 

Research data from Dr. Hamka, a professor at Uhamka University in Indonesia, reveals this point. Subsequently, research records from the University of Indonesia (UI) indicate that 61.5% of students are dual users.

 

Furthermore, individuals undergoing NRT treatment must be supervised by healthcare professionals. However, in Indonesia, the use of e-cigarettes for smoking cessation is carried out without any supervision.

 

Third, people receiving NRT treatment need to gradually reduce their nicotine dosage until completely quitting nicotine products. However, e-cigarette users in Indonesia do not require dosage reduction.

 

Fourth, non-smoking treatments typically last for three months before evaluation. In Indonesia, however, the majority of people actually continue to use e-cigarettes even after they quit using traditional cigarettes.

 

Agus, a professor of pulmonary disease and respiratory medicine at the International University of Indonesia, also stated that the most effective method for quitting smoking is to strengthen one's commitment. If the commitment is strong, healthcare workers are better able to provide assistance.

 

Forms of assistance can include smoking cessation medications, which have a success rate of 30% - 50%. If patients find it difficult to quit smoking using medication, non-pharmaceutical help such as hypnotherapy, psychotherapy, acupuncture, and medical rehabilitation may be required.

 

He stated that, "In general circumstances, the success rate can nearly reach 60-70% with the additional treatment options available, both through medication and non-medication."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Malaysia's Health Minister: Plans to ban the sale of e-cigarettes by mid-2026, starting with open-cell products
Malaysia's Health Minister: Plans to ban the sale of e-cigarettes by mid-2026, starting with open-cell products
Malaysia plans to ban and phase out all e-cigarette sales nationwide by mid-2026, pending cabinet approval.
Sep.26 by 2FIRSTS.ai
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Venture Faces New Judicial Auction, Control Unchanged
Jinjia Group said its controlling shareholder, Jinjia Venture, will have part of its holdings auctioned by the Shenzhen Nanshan Court, involving 43.4 million shares. Earlier, the Shenzhen Intermediate Court announced another auction of 37.27 million shares. Together they represent 5.56% of total equity. Jinjia said the auctions will not affect company control.
Oct.23 by 2FIRSTS.ai
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
UK Government Officially Confirms Vaping Products Duty and Stamps Scheme, Effective October 2026
HM Revenue & Customs (HMRC) has officially confirmed that the UK will implement a Vaping Products Duty (VPD) and Vaping Duty Stamps (VDS) scheme from October 1, 2026. The duty will apply to all vaping liquids at a flat rate of £2.20 per 10ml. Businesses must register for approval starting April 1, 2026. The stamps scheme will take effect in October 2026 with a six-month grace period, after which, from April 2027, unstamped products will be prohibited from sale.
Oct.02 by 2FIRSTS.ai
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Bangladesh Approves Philip Morris Factory for Nicotine Pouches, Sparks Controversy: Regulator Says It’s “Completely Legal”
Philip Morris Bangladesh Limited (PMBL) has received approval to invest USD 5.82 million in a nicotine pouch factory in Narayanganj. Regulators say the project is legal under existing laws, while health groups argue it breaches a 2016 Supreme Court order and poses youth addiction risks.
Nov.07 by 2FIRSTS.ai
Illegal Vape Sellers in the Netherlands Could Be Fined Up to €4,040
Illegal Vape Sellers in the Netherlands Could Be Fined Up to €4,040
The outgoing Dutch government plans to raise fines for illegal sales of vapes and cigarettes, with first-time offenders facing a €2,040 penalty. The new fines, up to €4,040 for large companies, are expected to take effect on July 1, 2026, pending parliamentary approval.
Nov.10 by 2FIRSTS.ai
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
Reuters: FDA relaxes requirements for nicotine pouch pilot program, cancels special research on some products
US FDA meeting minutes: Under Trump, a new pilot eases nicotine pouch rules—cuts product-specific research (uses generic data), shortens reviews, boosts communication. It’s the FDA’s first clear softer stance on smoking alternatives. The pilot may benefit Philip Morris (Zyn), Altria (On!), BAT (Velo) but sparks debate: FDA says pouches are low-risk (no youth surge), while ex-officials/academics cite missing research (hurts health checks, risks hidden youth use). Firms note costly research remain
Sep.19 by 2FIRSTS.ai